TODAY -

Latest advancements in TB science in spotlight

Bobby Ramakant *



Important game-changing scientific advancements in preventing and treating TB (TB or tuberculosis, is among the deadliest of infectious diseases globally), were in spotlight at the recently concluded International Conference on Retroviruses and other Opportunistic Infections (CROI 2022).

If we look at the pace at which new better tools to prevent, diagnose, or treat TB have come in the past decades, it is a deeply painful realisation because despite scientific advancements, the pace of TB research and investment that has gone into it, is way off mark.

We still use more than a century old diagnostics, drugs that are too toxic, therapies that are too long and may cause post-treatment disabilities, treatment outcomes that can never be accepted as 'gold standard', and half-heartedly made measly investment promises, continue to hold us back in the fight to #endTB. That is why listening to new TB science updates at CROI 2022 was in particular a ray of hope for me.

Latest TB science updates included those regarding two most historically neglected areas: treatment for drug-susceptible TB (common TB when bacteria is not resistant to medicines) and latent TB (TB prevention). “Advancing TB science is vital because it is TB that is robbing us of gains made in advancing HIV treatment science and rollout. TB is the most common opportunistic infections among people living with HIV and a major cause of untimely deaths among them.

In 2020, there were 214,000 deaths from TB among people living with HIV. Even one TB death is a death too many. When TB is preventable, when TB is curable, then how can even one TB death occur in any sane and just society? We have to walk the talk on oft-chanted #EverylifeMatters,” said Shobha Shukla, founder of CNS (Citizen News Service) who was on the panel “CROI 2022: Global Advocates Offer Insights and Directions on the Science and Next Steps Needed.”

Harry Tembo, Zambia Community Advisory Platform, Zambia; Katie Willingham, The Well Project, United States; Richard Jefferys, Treatment Action Group, United States; Shobha Shukla, CNS, India; and Simon Collins, i-Base and EATG, United Kingdom were among the panelists and session was moderated by HIV prevention research stalwart-advocate Jim Pickett.

Latest advancements in drug-susceptible TB

Study 31/A5349 found that a new treatment regimen (combination of medicines) for treating drug-susceptible TB of the lungs in adults and adolescents, can effectively and safely cure TB in 4 months, instead of 6 months (when treated with current standard regimens). This new regimen used in the study had a combination of 4 medicines: Isoniazid, Rifapentine, Moxifloxacin, and Pyrazinamide.

The study concluded that this new regimen of 4 months was non-inferior to the current standard regimen of 6 months. In fact the overall efficacy results for HIV positive sub-group were higher at 85% as compared to 78% cure rate for participants who were living with HIV in the standard of care regimen group. This regimen is the first successful short-course treatment regimen for drug-susceptible TB disease in almost 40 years. WHO has endorsed this regimen for use [CDC guidance is forthcoming], said Shobha Shukla.

New research for treating TB in children

Another study called SHINE which was done in Africa and India, compared outcomes using a treatment regimen for 4 and 6 months respectively to treat smear-negative and non-severe forms of TB of the lungs in children (HIV positive and negative both included). Isoniazid, Rifampicin, Ethambutol and Pyrazinamide were the medicines used in the regimen. Study concluded that the 4-months duration therapy was non-inferior to standard 6-months duration therapy. Only 3% unfavourable outcomes and few toxicity related side-effects were reported in both groups (4 and 6 months duration treatment groups).

New research for better MDR-TB preventive treatments

Many ongoing studies are evaluating 6-months multi drug-resistant TB (MDR-TB) preventive therapies for close contacts of MDR-TB patients. TB CHAMP study is examining Levofloxacin medicine to be used as part of MDR-TB preventive therapy in children below 5 years of age, who are close contacts of adult MDR-TB patients.

PHOENix (Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients) study is comparing Delamanid with Isoniazid for preventing MDR-TB in children, adolescents and adults who are close contacts of persons with MDR-TB.

V-QUIN study in Vietnam is examining the efficacy of Levofloxacin for treating latent MDR-TB in all household contacts of patients with bacteriologically-confirmed Rifampicin-resistant TB.

Research ongoing for long-acting injectables for treating TB

Long-acting injectable possible formulations of TB drugs could have several potential benefits, like improved adherence, greater acceptability, and better integration of TB preventive therapy into other treatment programmes, like those for HIV, maternal and child health, said Shobha Shukla.

CROI also shared information on new TB drugs, including long acting injectables, that are in various stages of development: TBAJ-876, a next generation diarylquinoline, is in phase-1 of multiple ascending dose (MAD) study. It has shown improved safety, pharmacokinetics and superior potency. Sutezolid and Delpazolid are new oxazolidinones in phase 2b/2c studies.

DprE1 inhibitors (a novel class of anti-TB agents) are also being developed. OPC-167832, in combination with Bedaquiline and Delamanid, is being evaluated for safety and efficacy of a 4-months regimen for drug-sensitive TB. GSK3036656, a novel translational inhibitor, has been found to be safe and well tolerated after single and multiple doses in its First-Time-in-Human Study for shorter treatment regimen.

Existing TB drug Bedaquiline could be a potential suitable candidate for long acting injectable. One single dose of long acting formulation of Bedaquiline was found to maintain drug and metabolite concentration for up to 3 months in mice. Modelling results expect that this would also be observed in the clinic. New diarylquinolines (like TBAJ-876) may be good candidates for long-acting TB preventive therapy.

Treatment of MDR-TB

Until recently, the standard of care MDR-TB treatment regimen was 18-24 months long and gave a cure of around 50% with highly toxic drugs and painful daily injections given for a minimum of the first 6-months of treatment.

TB PRACTECAL study led by MSF is evaluating a 6 months all oral regimens containing Bedaquiline and Pretomanid in combination with Linezolid, Moxifloxacin and Clofazimine. The study design has 4 groups: one group gets the WHO standard of care regimen; second group gets a regimen of Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin; third group gets a regimen of Bedaquiline, Pretomanid, Linezolid, and Clofazimine; and fourth group gets a regimen of Bedaquiline, Pretomanid, and Linezolid.

As of now, a regimen of Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin, with a tapered dose of Linezolid, has been found to be non-inferior (safe and efficacious) to the standard of care (9-24 months) treatment of rifampicin-resistant TB of the lungs. Outcomes of other regimens are expected to be reported soon.

Nix-TB and ZeNix studies have already found an all-oral short-course 6-months treatment regimen of Bedaquiline, Pretomanid and Linezolid, for highly drug-resistant TB patients (MDR-TB, XDR-TB, pre-XDR-TB) to be safe and efficacious with a treatment success rate of 90% even in HIV infected MDR-TB patients. In ZeNix study, Linezolid dosage was reduced from 1200 mg to 600 mg to decrease toxicity, and duration was reduced from six months to two months, without affecting treatment success rate.

Preventing TB cannot be on the backseat

"Globally Directly Observed Treatment Shortcourse (DOTS) has been in use since 1980s. In India it was launched in 1997 as part of the Revised National TB Control Programme (RNTCP) which is now known as National TB Elimination Programme or NTEP. This current standard DOTS therapy (6 months long regimen) for TB treatment is a lifesaving therapy for those who do not have drug-resistance and get cured, but we cannot forget that this is not the gold standard by any means - this therapy remains burdensome to patients and their care providers, and toxic for many. We need better, more effective, less toxic, shorter treatment for drug-sensitive TB too," said Shobha Shukla.

She added: "For MDR-TB and extensively drug-resistant TB (XDR-TB) treatments, governments need to implement scientifically proven, shorter, and patient-centric treatment options with reduced number of drugs and minimal side effects."

"Why is there an unacceptably-long delay in rolling out best of science outcomes to those people who are most in need?" asks firebrand feminist and health rights activist Shobha Shukla.

Shobha said that testing and treating active TB disease is not enough if we want to end TB worldwide, unless we diagnose those with latent TB infection (especially those who are at greater risk) and provide them TB preventive treatments so that their risk of getting active TB disease is as low as possible. Not only we have not addressed latent TB infection adequately - historically - but we have even rolled existing programmes unsatisfactorily.

For example, in India use of Isoniazid preventive therapy (IPT) to reduce risk of active TB disease in children and people living with HIV with latent TB was offered even before rollout of lifesaving antiretroviral therapy (ART) began in 2004. But the ground reality of IPT rollout after almost two decades, is simply unacceptable.


* Bobby Ramakant wrote this article for e-pao.net
The writer is a World Health Organization (WHO) Director General’s WNTD Awardee 2008 and serves on the CNS (Citizen News Service) editorial.
Follow him on Twitter @BobbyRamakant
This article was webcasted on May 26 2022.



* Comments posted by users in this discussion thread and other parts of this site are opinions of the individuals posting them (whose user ID is displayed alongside) and not the views of e-pao.net. We strongly recommend that users exercise responsibility, sensitivity and caution over language while writing your opinions which will be seen and read by other users. Please read a complete Guideline on using comments on this website.




LATEST IN E-PAO.NET
  • ILP Check point at Jiri : Gallery
  • COVID-19 Status 27 June : Govt of Manipur
  • The untold story, lest it be forgotten
  • Assistance to victims of Assam Flood
  • A glimpse of 'Yangna Paikhredako Punshi'
  • Market innovations in developing country
  • COVID-19 : Impact in Manipur :: News Timeline
  • Anti-drug day expose state pathetic situation
  • The wedge amongst the Nagas
  • Coming of Manipur University in 1980
  • COVID-19 Status 26 June : Govt of Manipur
  • Laitonjam Lanchenba: Best Swimmer
  • Our capital Imphal - the city of sanity
  • Workshop : ND & PS Act, 1985
  • Mara Prabhu - Lord of the trees
  • Essence of international anti-drug day
  • July 1 : Taking the fight to plastic
  • Miss Shirui Lily 2022 #3 : Gallery
  • COVID-19 Status 25 June : Govt of Manipur
  • Flesh Trade : Connection between Goa & NE
  • Importance of Soil Testing & Management
  • ST status Vs Classical language for Meetei
  • Life, faith and belief
  • MANISFA General Secretary appointed
  • Flood Watch : 23rd June #2 : Gallery
  • COVID-19 Status 24 June : Govt of Manipur
  • Community led in ensuring HIV treatment
  • Approach to ideology & development
  • Solar Energy solution for healthcare facility
  • Yoga for health, beauty and immunity
  • Innovation Prize Launched for Designers
  • Knotty higher education sector
  • Classical language status and ST demand
  • Flood Watch : 23rd June #1 : Gallery
  • COVID-19 Status 23 June : Govt of Manipur
  • Birds and Bees Talk launched 3rd phase
  • Luck matters, Rio's first entry into cabinet...
  • Need to deal with dumping of waste materials
  • Training on mushroom at Nagamapal
  • 1961 as base year: Take it or leave it
  • 10 years too late : JCILPS
  • Phamnaiba Jagoi @ Thangjing : Gallery
  • COVID-19 Status 22 June : Govt of Manipur
  • Women's cleanliness enjoys equal rights...
  • Life in some hill villages
  • The MCI Restoration II
  • 'BRO Cafes' on 75 border roads
  • Protest over boundary row headache for Govt
  • Issues on the indigenous question
  • Drug Menace In Manipur : Gallery
  • COVID-19 Status 21 June : Govt of Manipur
  • ST tag for Meiteis - A perspective!
  • Manipur State Welfare : Politics 1-0 Citizens
  • International Yoga Day at Assam Rifles
  • International Yoga Day at IBSD Imphal
  • International Yoga Day at NSU Imphal
  • Manipur Lokyukta: Fighting against corruption
  • Vision to distribute local rice under NFSA...
  • Taking the fight to the drug menace
  • Landslides - Imphal-Jiri [Jun 17] : Gallery
  • COVID-19 Status 20 June : Govt of Manipur
  • Thangjing in folklore of Koireng tribe
  • Health Workshop on Diabetes at Pune
  • Everyone is a thief :: Poem
  • E- barton for CM & Governor
  • Intensive cultivation of vegetables
  • High time to encourage e-vehicle operators
  • Scripting success story with Rs 500
  • Leima Jagoi by Transgender #1 : Gallery
  • COVID-19 Status 19 June : Govt of Manipur
  • June 19 2022 : Father's Day message
  • Nine Hills One Valley : Ottawa Film Fest
  • Shirui Lily Festival or mud festival ?
  • Yoga for Women organised
  • Flight link to Mandalay dream come true
  • Action of Govt needs to be backed
  • 21st Great June Uprising #1 : Gallery
  • COVID-19 Status 18 June : Govt of Manipur
  • The Great June 18 Uprising :: News Timeline
  • Revive environmentalism in Meetei ethos
  • COVID-19 Status 17 June : Govt of Manipur
  • Elephant army of Lord Guruvayurappan
  • Who will be next at Rashtrapati Bhawan
  • Hiyang Tannaba @ Loktak #1 : Gallery
  • Freedom movement against British #2
  • Inequity and health security
  • Donating blood is an act of solidarity
  • Unregulated deposit schemes & BUDS Act
  • Extension of entry age : Agnipath
  • Citizens feeding on adulterated food items
  • Of food safety and street vendors
  • Pooja Elangbam, IAS, 81st ranker in AICS
  • COVID-19 Status 16 June : Govt of Manipur
  • NE Model @Delhi Kids Fest : Gallery
  • Manipur Rajkunja
  • Effective Legal Aid to Women Prisoner
  • How to avoid cracked heel during hot summer
  • Aid to artisan must to promote local product
  • Education for whom ?
  • Kabui Dance @Nongshaba Haraoba : Gallery
  • COVID-19 Status 15 June : Govt of Manipur
  • 'Let's Talk About It' : music album
  • Significance of World Environment Day
  • The MCI Restoration
  • North East CSR Award 2022
  • Prolonged sitting or standing spoils your leg
  • State fast-tracking towards drug making hub
  • 'Progression' from smuggling to manufacturing
  • Bonny Elangbam : Longest distance covered
  • COVID-19 Status 14 June : Govt of Manipur
  • Interaction with Makakmayum Hosni Mubarak
  • India to become $5 trillion economy
  • Exploring traditional medicines of NE
  • Freefall of the kids after COVID-19
  • Honour the tax payers, expose defaulters
  • NE needs more than 'unprecedented'
  • Miss Shirui Lily 2022 #2 : Gallery
  • COVID-19 Status 13 June : Govt of Manipur
  • Water management in paddy cultivation
  • PM Modi hails Nagaland Gaon Burahs
  • Blight of Nature :: Poem
  • Moreh as Las Vegas
  • NHIDCL's reputation at stake
  • Drugs, poppy & 'alternatives'
  • Thaopai Shithaine of Poumai #2 :: Gallery
  • COVID-19 Status 12 June : Govt of Manipur
  • Jadonang Park, Tamenglong :: Gallery
  • Freedom movement against British #1
  • Multi-Tasking Staff at Leima Traders
  • Toning down rhetoric that hurts religion
  • Shirui Lily fest brings to fore plastic menace
  • Conservation of pony & grazing fields
  • Kakwa Lairembi Haraoba #2 :: Gallery
  • COVID-19 Status 11 June : Govt of Manipur
  • The unheeded cry of children in labour
  • Why present distribution of urea fails?
  • World Day Against Child Labour 2022
  • Sunrise on the Civil Aviation Horizon
  • Arambam Samarendra Ningshingba :: Gallery
  • COVID-19 Status 10 June : Govt of Manipur
  • NE Ex-Super Model at Delhi Kids Fest
  • What Diphu has, Dimapur & Kohima don't
  • Towards Manipur Budget 2022-23 ...
  • NE Social & Behaviour Change inaugurated
  • Fighting corruption remains an uphill task
  • Environment needs more than tree plantation
  • SN Chand: The father of Manipuri cinema #3
  • COVID-19 Status 09 June : Govt of Manipur
  • Degree Certificate for Survival #2
  • Value chain management of Umorok
  • Pulses for Nutrition Security in Manipur
  • Keeping your skin oil free during summer
  • Demand for impartial probe into IMC scam
  • Politics of isolating the NSCN (IM)
  • Raas @Manipur Rajbari, W Bengal :: Gallery
  • COVID-19 Status 08 June : Govt of Manipur
  • A rare book on Birds of Manipur
  • Condemns bomb blast in Manipur
  • Market Innovations made America great #2
  • Jal Jeevan Mission : PHED Manipur
  • Disturbing data on lifestyle diseases in state
  • Tough talk against drug menace
  • Trekking to Shirui Peak, Ukhrul #2 :: Gallery
  • COVID-19 Status 07 June : Govt of Manipur
  • Take a leaf from sunderban if you're serious
  • Testimony of brother Ninghor Mahongnao
  • Local leaders unitedly push for One Health
  • Letters from the Republic of Dust #2
  • Soil testing for better crop production
  • Despicable threat to school
  • Outrage at Little Flower School
  • Ibudhou Thangjing Lam Thokpa #3 :: Gallery
  • COVID-19 Status 06 June : Govt of Manipur
  • India-Taiwan Global Bamboo Tech Forum
  • Condemns bomb attack at LFS
  • RSS chief sounds logical
  • Career options in Environmental Science
  • We reap what we sow
  • NRC in focus as keyboard warriors spar...
  • Coming together of COCOMI, UNC
  • HSE Result 2022 : Statistiscal Abstract
  • HSE Result 2022 : Subject Pass Percentage
  • HSE Result 2022 : District-Wise Pass %
  • HSE Result 2022 :Science Topper
  • HSE Result 2022 : Arts Topper
  • HSE Result 2022 : Commerce Topper
  • HSE Result 2022 : Science Stream Result
  • HSE Result 2022 : Arts Stream Result
  • HSE Result 2022 : Commerce Stream Result
  • COVID-19 Status 05 June : Govt of Manipur
  • Nagaland: Is it fair to blame Indrajit Gupta ?
  • 4th Plenary Session of WMC at Sugnu
  • World Environment Day at Tamenglong
  • World Environment Day at Lilong
  • World Environment Day at Haraorou
  • Musing :: Poem
  • Yet another World Environment Day observed
  • Mounting pressure for solution
  • Padmashree Award Moirangthem Muktamani
  • COVID-19 Status 04 June : Govt of Manipur
  • Congested road at Shirui Village :: Gallery
  • Degree Certificate for Survival #1
  • Admission for National Sports University
  • World Environment Day at Imphal
  • Include Meeteis in the ST list
  • Inhumane act of De-addiction centres
  • UK band Monuments @ShiRock #2 :: Gallery
  • COVID-19 Status 03 June : Govt of Manipur
  • 'Provocation' charges arrests on social media
  • Gerinda Loitongbam: Natl Women Award
  • Timeless Memories :: Poem
  • Ket Meth releases music video Trauma'
  • 8 years of Modi Govt: More hits than misses
  • Bad example commanders
  • Posers parents may raise within
  • Miss Shirui Lily 2022 #1 : Gallery
  • COVID-19 Status 02 June : Govt of Manipur
  • Letters from the Republic of Dust #1
  • Workshop on Food Processing at Lilong
  • 1st June is the Global Day of Parents
  • 'Developing human resource in Manipur'
  • Swachh Bharat Mission (Grameen)
  • 'Yoga for personality development' orgd
  • Row over boundary fencing project
  • Brain storming session of the Congress
  • Lunghar (Imp-Kohima / Jessami) #3 : Gallery
  • COVID-19 Status 01 June : Govt of Manipur
  • Delphi Oinam : Topper at Nagaland HSLC
  • Teaching at Churachandpur Govt College
  • Jadonang Park at Tamenglong renovated
  • Quality seed production of rice (HYV)
  • Audiobook for NEET aspirants launched
  • Naga issue: From bush war to shadow boxing
  • Tenants in Nagaland tag on the NSCN (IM)
  • Wakhom Leikai Lairembi Haraoba #2 : Gallery
  • COVID-19 Status 31 May : Govt of Manipur
  • Pageant winners showcase Robert's collection
  • MIFF to pay homage to Irom Maipak
  • Awareness on Legal rights of women prisoner
  • Election petitions galore in Manipur
  • Training program on mushroom at Nagamapal
  • Must expedite process for border projects
  • Wanted : A far sighted leader
  • Naga Indigenous Wrestling :: Gallery
  • June Calendar for Year 2022 : Tools
  • UK band Monuments @ShiRock #1 :: Gallery
  • Ibudhou Thangjing Lam Thokpa #2 :: Gallery
  • SN Chand: The father of Manipuri cinema #2
  • Licypriya speech at East Timor :: Gallery
  • On 200th Anniversary of MK Binodini Devi
  • Featured Front Page Photo 2022 #2: Gallery
  • Harvesting Fest of Tarao #4 :: Gallery
  • Id-ul-Fitr @Hatta Golapati :: Gallery
  • Rules of English Pronunciation : Download
  • Sub-Syllables in English : Book Download